Shareholders tried to file a class action lawsuit against the company for allegedly violating federal securities laws by issuing misleading public statements relating to a December 2004 announcement of Mucotrol's clearance by the FDA. The United States District Court for the Southern District of New York has dismissed the case without prejudice. (Oct-04-05)
[PHARMA LIVE]
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
